Evidence map›Paper›PMID 40641625›Full record

ReviewFrontiers in neuroscience2025

Inflammatory links between epilepsy and depression: a review of mechanisms and therapeutic strategies.

Yu-Qian Shi, He-Cai Yang, Cong He, Yu-Hao Wang, Jia Zheng, Xing-Yi Wang, Fang-Yi Hao, Chu-Wen Feng, Lin Ma, Yue-Hui Zhang and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu-Qian ShiFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
He-Cai YangFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Cong HeThe Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Yu-Hao WangFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Jia ZhengFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Xing-Yi WangFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Fang-Yi HaoFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Chu-Wen FengThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Lin MaThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Yue-Hui ZhangThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Zheng LiuThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is the most common psychiatric comorbidity of epilepsy. While antiseizure medications (ASMs) can exacerbate depressive symptoms, depression itself may increase both the frequency and duration of epileptic seizures. The pathophysiological mechanisms underlying epilepsy-depression comorbidity (EDC) involve neurotransmitter imbalance, inflammatory responses, oxidative stress (OS), gut microbiota dysbiosis, and neuroendocrine abnormalities. Recent studies highlight that inflammation contributes to EDC via multiple interconnected mechanisms, including glial cell activation, cytokine release, pyroptosis, and oxidative damage, ultimately leading to synaptic dysfunction and neuroimmune imbalance. Drawing from representative and recent evidence, this review summarizes the role of inflammation in the pathogenesis and progression of EDC. It also outlines current inflammation-targeted therapeutic strategies, such as anti-inflammatory drugs, antioxidants, herbal medicine, acupuncture, probiotic modulation, and precision therapies. This review provides a conceptual framework for understanding inflammation-mediated EDC and offers insights into targeted treatment approaches.

Indexed as

aging-related inflammationepilepsy-depression comorbiditygut-brain axisnatural anti-inflammatory agentsneuroinflammation

Identifiers

PMID40641625
PMCPMC12241093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.